1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Can Fite BioPharma Ltd (CANF)
  7. News

CANF

Can Fite BioPharma News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Can Fite BioPharma Ltd CANF AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0086 1.02% 0.855 19:39:50
Open Price Low Price High Price Close Price Prev Close
0.84 0.84 0.865 0.865 0.8464
more quote information »

Recent News

Date Time Source Heading
7/11/202207:14EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/11/202207:00BWCan-Fite to Submit FDA & EMA Registration Plans for..
6/29/202210:35TRMNH.C. Wainwright Thinks Can-Fite BioPharma’s Stock is Going..
6/29/202207:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/29/202207:00BW Can-Fite Announces Positive Top-Line Results from..
6/24/202207:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/24/202207:00BWCan-Fite’s CF602 Reverses Erectile Dysfunction in Diabetic..
6/09/202207:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/09/202207:00BWCan-Fite Announces Publication of Clinical Study Data for..
5/29/202208:15TRMNDawson James Thinks Can-Fite BioPharma’s Stock is Going to..
5/26/202207:00BWCan-Fite Reports First Quarter 2022 Financial Results &..
5/16/202207:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/16/202207:00BWCan-Fite Granted Key NASH Patent in Israel
5/02/202207:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/02/202207:00BWCan-Fite’s CEO to Present Namodenoson’s Efficacy in Liver..
4/06/202206:25TRMNCan-Fite BioPharma (CANF) Receives a Buy from H.C...
4/05/202212:20SEEKCan-Fite reports positive data from preclinical trial of..
4/05/202207:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/05/202207:00BWCan-Fite is Developing a Topical Piclidenoson Psoriasis..
3/28/202207:00BWCan-Fite to Present at Dermatology Drug Development Summit..
3/27/202208:15TRMNDawson James Keeps Their Buy Rating on Can-Fite BioPharma..
3/25/202216:31EDGARPost-effective Amendment to Registration Statement (pos Am)
3/24/202209:39EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/24/202209:21SEEKCan-Fite Biopharma GAAP EPS of -$0.03, revenue of $0.85M
3/24/202208:30BWCan-Fite Reports 2021 Financial Results & Provides Clinical..
3/14/202208:56SEEKCan-Fite stock rises 8% on notice of allowance of patent for..
3/14/202207:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/14/202207:00BWCan-Fite: Namodenoson’s Treatment of Liver Fibrosis Receives..
3/11/202207:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/11/202207:00BWCan-Fite’s Findings in the Treatment of Liver Diseases with..
3/08/202207:30SEEKCan-Fite delays topline data from late-stage psoriasis trial..
3/08/202207:15EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/08/202207:00BWCan-Fite’s Phase III Psoriasis Study Data Expected Q2 2022
2/11/202206:53EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202216:00EDGARAmended Statement of Ownership (sc 13g/a)
1/31/202209:04SEEKCan-Fite begins enrollment in phase 2b trial of namodenoson..
1/31/202207:00BWCan Fite Announces First Patient Enrolled in Phase IIb NASH..
1/18/202206:30EDGARNotice of Effectiveness (effect)
1/14/202216:32EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/13/202208:12SEEKCan-Fite says Piclidenoson destroys pathological skin cells..
1/13/202207:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/13/202207:00BWPrior to Phase III Psoriasis Data Release Can Fite Reports..
1/10/202207:26BWCan-Fite to Conduct Investor Meetings during the J.P. Morgan..
1/07/202216:32EDGARSecurities Registration (foreign Private Issuer) (f-3)
1/07/202206:16TRMNH.C. Wainwright Thinks Can-Fite BioPharma’s Stock is Going..
1/05/202207:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/05/202207:00BWCan-Fite Issues Letter to Shareholders
1/05/202204:11TRMNDawson James Thinks Can-Fite BioPharma’s Stock is Going to..
12/30/202116:16EDGARSmall Company Offering and Sale of Securities Without..
12/29/202107:43SEEKCan-Fite BioPharma to file for patents after new findings..


Your Recent History
AMEX
CANF
Can Fite B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now